Pier Paolo Pandolfi left Harvard University last year following allegations of sexual harassment, and has since been accused of research misconduct.

A cancer researcher with a talent for leadership, Marks turned the Memorial Sloan Kettering Cancer Center into one of the world’s foremost oncology research institutions.

A study of 11 drugs now in clinical trials suggests they do kill cancer cells—but through a different mechanism than indicated in previous research.

The Creighton University researcher discovered the genetic basis of hereditary breast-ovarian cancer syndrome.

The Centers of Cancer Nanotechnology Excellence were established in 2005 through several phases of funding, which are reported to end next year.

The former head of cancer medicine at MD Anderson Cancer Center helped change clinical practice for laryngeal cancer and helped establish chemoprevention.

Nine of the most recent retractions from AACR journals are for papers coauthored by embattled cancer researcher Bharat Aggarwal.

Men received both more and larger grants than women did, ending up with three times as much funding on average.

3-D balls of cells can be used to screen for potential cancer drugs.